Notice to stakeholders: Considerations regarding the proposed use of psilocybin mushrooms in clinical trials, or as a drug accessed through the Special Access Program (SAP) - Notice to stakeholders: Considerations regarding the proposed use of psilocybin mushrooms in clinical trials, or as a drug accessed through the Special Access Program (SAP)

Additional Information

Field	Value
Data last updated	October 20, 2025
Metadata last updated	October 20, 2025
Created	October 20, 2025
Format	HTML
License	Open Government Licence - Canada
Has views	False
Id	f436d998-450b-4e32-8f62-4f7928c71627
Package id	ccd73f21-75da-4a95-bc49-ca62d1759611
Position	0
State	active